N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells

G Aquilina1, S Ceccotti, S Martinelli

  • 1Istituto Superiore di Sanità, Rome, Italy.

Cancer Research
|January 13, 1998
PubMed

Insights

Loss of mismatch repair (MMR) increases sensitivity to CCNU chemotherapy in some cancer cells. This suggests MMR

Area of Science:

  • DNA repair mechanisms
  • Cancer chemotherapy
  • Genomic instability

Background:

  • Mismatch repair (MMR) is crucial for correcting DNA replication errors.
  • N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea (CCNU) is a chemotherapeutic agent.
  • The relationship between MMR deficiency and CCNU sensitivity is not fully understood.

Purpose of the Study:

  • To investigate if loss of MMR function leads to increased sensitivity to CCNU.
  • To determine if this sensitivity is a general characteristic of MMR-deficient human tumor cells.
  • To explore the implications for treating MMR-deficient tumors.

Main Methods:

  • Compared the sensitivity of MMR-defective (MMR-) cell variants to their parental MMR-proficient (MMR+) counterparts.
  • Utilized various human tumor cell lines with different MMR and O6-methylguanine-DNA-methyltransferase (MGMT) statuses.
  • Administered CCNU and MGMT inhibitor O6-benzylguanine to assess drug response.

Main Results:

  • Loss of MMR conferred 2- to 5-fold hypersensitivity to CCNU in HeLa, Raji, and Chinese hamster ovary cells.
  • MMR-deficient tumor cells (AN3CA, LS174T, LoVo, DU145) showed 1.4- to 4.3-fold increased sensitivity to CCNU compared to MMR-proficient cells, particularly when MGMT was inhibited.
  • Hypersensitivity to CCNU was not observed in all MMR-deficient cell lines (DLD1, HEC1A, HCT116), indicating other factors influence drug response.
  • Loss of MMR was associated with tolerance to N-methyl-N-nitrosourea, a different type of DNA damaging agent.

Conclusions:

  • MMR deficiency can lead to hypersensitivity to CCNU, suggesting MMR's role in repairing CCNU-induced DNA damage, possibly interstrand cross-links.
  • The presence of MGMT significantly impacts CCNU resistance, independent of MMR status.
  • Further research is needed to understand the complex factors influencing CCNU sensitivity in MMR-deficient cells.
  • Findings may inform clinical strategies for treating MMR-deficient tumors with CCNU-based therapies.